Phase 1 Grade II Glioma Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Serial MR Imaging and MR Spectroscopic Imaging for the Characterization of Lower Grade Glioma

WHO Grade III GliomaWHO Grade II GliomaRecurrent WHO Grade III Glioma+1 more

Susan Chang300 enrolled1 locationNCT04540107

Recruiting

Phase 1

Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)

High Grade GliomaLow-grade GliomaRecurrent World Health Organization (WHO) Grade II Glioma

University of California, San Francisco50 enrolled17 locationsNCT04485559